Pharscin Pharma: Crizotinib capsules are expected to be launched for sale by the end of next year

Pharscin Pharma responded on the interactive platform on October 23rd, stating that Crizotinib capsules are currently under the patent protection period of the original research company and are expected to be available for sale by the end of next year. The sales of the drug are affected by various industry policies, and the company is currently unable to estimate the sales revenue